Top Markets
Coin of the day
China Biotech Services Holdings Limited China Biotech Services Holdings Limited

China Biotech Services Holdings Limited

8037
Rang in Aktien #23175
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech... Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
Aktienkurs
$0.07931426
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$77.39M
Veränderung (1 Tag)
0.81%
Veränderung (1 Jahr)
-49.20%
Land
HK
Handel China Biotech Services Holdings Limited (8037)

Kategorie

P/B-Verhältnis für China Biotech Services Holdings Limited (8037)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von China Biotech Services Holdings Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für China Biotech Services Holdings Limited von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US